Status: current, Defined. Date: 31-Jan 2022. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
4687728012 | Etamsylate 250 mg and tranexamic acid 250 mg oral tablet | en | Synonym | Active | Case insensitive | SNOMED CT core |
4687729016 | Product containing precisely etamsylate 250 milligram and tranexamic acid 250 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Etamsylate 250 mg and tranexamic acid 250 mg oral tablet | Has manufactured dose form | Conventional release oral tablet | true | Inferred relationship | Some | ||
Etamsylate 250 mg and tranexamic acid 250 mg oral tablet | Has unit of presentation | Tablet | true | Inferred relationship | Some | ||
Etamsylate 250 mg and tranexamic acid 250 mg oral tablet | Plays role | Haemostatic therapeutic role | true | Inferred relationship | Some | ||
Etamsylate 250 mg and tranexamic acid 250 mg oral tablet | Has precise active ingredient | Tranexamic acid | true | Inferred relationship | Some | 1 | |
Etamsylate 250 mg and tranexamic acid 250 mg oral tablet | Has BoSS | Tranexamic acid | true | Inferred relationship | Some | 1 | |
Etamsylate 250 mg and tranexamic acid 250 mg oral tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
Etamsylate 250 mg and tranexamic acid 250 mg oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Some | 1 | |
Etamsylate 250 mg and tranexamic acid 250 mg oral tablet | Has precise active ingredient | Etamsylate | true | Inferred relationship | Some | 2 | |
Etamsylate 250 mg and tranexamic acid 250 mg oral tablet | Has BoSS | Etamsylate | true | Inferred relationship | Some | 2 | |
Etamsylate 250 mg and tranexamic acid 250 mg oral tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 2 | |
Etamsylate 250 mg and tranexamic acid 250 mg oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Some | 2 | |
Etamsylate 250 mg and tranexamic acid 250 mg oral tablet | Is a | Etamsylate and tranexamic acid only product in oral dose form | true | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets